Navigation Links
Sanofi-aventis Oncology Data to be Presented at San Antonio Breast Cancer Symposium
Date:12/9/2010

BRIDGEWATER, N.J., Dec. 9, 2010 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the final survival analysis (10-year follow-up) of the BCIRG001 study that included a Taxotere® (docetaxel) Injection Concentrate chemotherapy treatment regimen in the adjuvant breast cancer setting, as well as data from iniparib (BSI-201) pre-clinical and clinical breast cancer studies will be featured during the 33rd Annual San Antonio Breast Cancer Symposium (SABCS) in San Antonio, Texas from December 8 to 12, 2010.  

During SABCS, the final (10-year follow up) survival analysis of the BCIRG001 study that included sanofi-aventis' chemotherapy drug Taxotere, in combination with doxorubicin and cyclophosphamide, in women with operable node-positive breast cancer will be presented. Also being presented are data from pre-clinical and clinical studies involving the sanofi-aventis investigational compound iniparib (BSI-201), which is being studied in breast cancer.  Iniparib is a novel investigational small molecule with poly (ADP-ribose) polymerase (PARP) inhibitory activity.

Key events at SABCS include: Taxotere Data:Abstract #S4-3

Friday, Dec. 10

3:45 PM CSTAn oral presentation featuring final results from the ten-year follow-up analysis of the BCIRG 001 trial Iniparib Data:Abstract #P5-06-09

Phase 1b/2 MBC trial

Saturday, Dec. 11

5:30 - 7:30 PM CSTData from a Phase 1b study to assess the safety and tolerability of the investigational compound iniparib (BSI-201) in combination with irinotecan in patients with metastatic breast cancer (MBC)Iniparib Data:Abstract # P6-04-12

Activity in TNBC Cell lines

Sunday, Dec. 12

7:00 - 8:30 AM CSTData from a preclinical study assessing the cell cycle effects of the investigational compound iniparib (BSI-201) in combination
'/>"/>

SOURCE sanofi-aventis
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Sanofi-aventis Sends Letter to Genzyme Seeking Clarification on Potential Board Actions
2. Covance and sanofi-aventis Finalize Agreements for 10-year Strategic R&D Alliance
3. Sanofi-aventis to Acquire BMP Sunstone Creating a Strong Consumer Healthcare Platform in China
4. Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis
5. Sanofi-aventis Commences Tender Offer to Acquire All Outstanding Shares of Genzyme for $69 per Share in Cash
6. Covance and Sanofi-Aventis Sign Definitive Agreements for 10-Year Strategic R&D Alliance
7. European Hospital Anticoagulant Market Dominated by Sanofi-Aventiss Clexane
8. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
9. Sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme
10. Sanofi-Aventis and Novalar File Marketing Authorization Application for OraVerse® in Five Key European Countries
11. Oramed Pharmaceuticals and sanofi-aventis Enter Into an Agreement for the Insulin Supply of Orameds Oral Insulin Capsules
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013   Voices Against ... finding a cure for brain cancer, today announced that ... grant to support the clinical investigation of Toca 511 ... high grade glioma brain cancer (Grade 3 or Grade ... novel treatments for advanced cancer, with an initial focus ...
(Date:6/19/2013)... BETHESDA, Md. , June 19, 2013 /PRNewswire/ -- ... "Company"), an American healthcare company providing services in ... of United Family Healthcare, a network of private ... official opening of its Beijing United Family Rehabilitation ... development projects of the United Family Healthcare ("UFH") ...
(Date:6/19/2013)... -- BD Biosciences, a segment of BD (Becton, Dickinson and ... technology company, today announced the launch of the BD ... of high-performance research flow cytometers. The BD ... most compact footprint in its class at just 30" x ... (76.2 cm). Recognizing that space is a valuable commodity in ...
Breaking Medicine Technology:Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 2Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 3Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 4Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 5New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research 2
(Date:6/19/2013)... In what is believed to be the largest follow-up ... hereditary dystonia a movement disorder that can cause ... report good success rates and lasting benefits. , Michele ... at Cedars-Sinai Medical Center,s Department of Neurology, and Ron ... at Beth Israel Deaconess Medical Center in Boston, published ...
(Date:6/19/2013)... Arbor, Mich. Children had half as many ... evening office hours on five or more days a ... at C.S. Mott Children,s Hospital and Johns Hopkins University. ... in The Journal of Pediatrics and will ... "These findings are an important step in understanding where ...
(Date:6/19/2013)... no-strings sexual encounters are increasingly common on college ... others to "hook up"? A new study by ... and Preventive Medicine, published online by the ... certain factors and behaviors associated with sexual hookups, ... the potential for negative emotional and physical health ...
(Date:6/19/2013)... for repairing damage to the genetic material DNA become ... seem, those compounds are sparking optimism as potential treatments ... in BRCA, a gene that made headlines when actress ... termed PARP inhibitors, are the topic of the cover ... Engineering News . C&EN is the weekly news magazine ...
(Date:6/19/2013)... Center and colleagues at Louisiana State University have developed ... immediate therapy. It relies on understanding the genetic interaction ... better predict a prostate cancer,s aggressiveness to avoid unnecessary ... the online journal PLOS ONE in April. ... 20 percent of all cancers and 9 percent of ...
Breaking Medicine News(10 mins):Health News:Long-term study reports deep brain stimulation effective for most common hereditary dystonia 2Health News:Extended primary care office hours might help keep kids out of the emergency department 2Health News:Why are some college students more likely to 'hook up'? 2Health News:Moffitt Cancer Center researchers identify genetic variants predicting aggressive prostate cancers 2
... investigators say , MONDAY, July 6 (HealthDay News) -- ... that help breast cancer cells survive in the bone marrow ... the July issue of the journal Cancer Cell , ... according to the researchers. , "We sought to identify signaling ...
... study suggests, , MONDAY, July 6 (HealthDay News) -- Children ... diabetes, rheumatoid arthritis and celiac disease have up to ... finds. , Although the association between autism and a maternal ... found in earlier research, the researchers behind the new study ...
... Every year as many as seven million adults in ... systematic review of the scientific literature on delirium prevention ... the Regenstrief Institute and Wishard Health Services found that ... for hospitalized adults, no effective way to prevent or ...
... study to determine the non-medical factors that may be ... researchers at Columbia University Mailman School of Public Health ... of chemotherapy in elderly women with breast cancer and ... if treated by oncologists employed in a private practice. ...
... , IRVINE, Calif., July 6 Quest International, Inc. announced ... Healthcare,s Best Global Supplier of the Year Award. This ... presented with the award, receiving honors in 2006 as well. ... 2009 Siemens Annual Supplier Conference. Quest was selected for ...
... of one of the nation,s largest Medicare chronic condition special ... care for seniors with chronic illness, today announced the appointment ... effective August 1, 2009. , , Prior to ... CEO of United HealthCare,s Evercare healthplans, the business unit that ...
Cached Medicine News:Health News:Research Reveals Clues to Breast Cancer's Spread 2Health News:Autism May Be Linked to Mom's Autoimmune Disease 2Health News:Autism May Be Linked to Mom's Autoimmune Disease 3Health News:Autism May Be Linked to Mom's Autoimmune Disease 4Health News:Delirium in hospitalized adults: Situation critical, no relief available 2Health News:Elderly breast cancer patients receive chemotherapy if treated in private practices 2Health News:Elderly breast cancer patients receive chemotherapy if treated in private practices 3Health News:Quest International Repeats Win as Siemens Healthcare Best Global Supplier of the Year 2Health News:Quest International Repeats Win as Siemens Healthcare Best Global Supplier of the Year 3Health News:Dr. John Mach Appointed Chief Medical Officer at XLHealth 2
... HRR 4th edition pseudoisochromatic test from Richmond ... screener plates and the 14 diagnostic series for ... plates has its own tab for easy and ... set of instructions in English and a laminated ...
Ishihara test chart book for color blindness. 14 plate. A simple accurate method for discovering congenital color blindness....
Ishihara 14 plate color vision testing set. Suitable for screening purposes....
Accepted by leading authorities as a simple and accurate method for discovering congenital color blindness of two type total color blindness and red/green blindness. This book is used for children an...
Medicine Products: